Abbott Laboratories news

   Watch this stock
Showing stories 1 - 10 of about 114   

Articles published

ABT 49.54 +0.46 (0.94%)
price chart
Abbott Labs to Vote in Favor of Mylan's Perrigo Deal
“As both Mylan's largest shareholder and its partner through our continued manufacturing relationships, we believe Mylan's stand-alone strategy and acquisition of Perrigo will further enhance its platform,” Abbott Chief Executive Miles White said.
Shareholder Abbott Laboratories supports Mylan's bid for Perrigo  Pittsburgh Post-Gazette
Abbott Laboratories to vote for Mylan NV's acquisition of Perrigo ...  Economic Times
Active Stocks News Buzz: Abbott Laboratories (NYSE:ABT), Barclays PLC ...
Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome ...
Large Inflow of Money Witnessed in Abbott Laboratories
Abbott Laboratories (NYSE:ABT) traded with a cut of -0.96 points or -1.92% at $49.01 per share. As per the last available information, the stock aggregated $50.46 million in upticks and $34.64 million in downticks, keeping the net money flow capped at ...
Shares of Abbott Laboratories (NYSE:ABT) Sees Large Inflow of Net Money Flow  Insider Trading Report
Abbott Laboratories (NYSE:ABT) Ratings Update  Investor Newswire
Technical Report on Abbott Laboratories (NYSE:ABT)
[PRNewswire] Abbott Laboratories (NYSE:ABT)(TREND ANALYSIS) announced that it has received CE Mark for the latest advancement of its Absorb stent system, called Absorb GT1™, which combines the world's first fully dissolving stent with a ...
Abbott Laboratories (NYSE:ABT)'s Senior Vice President Jeanyves Pavee ...  OctaFinance.com
Zacks Rating on Abbott Laboratories  American Trade Journal
Abbott Laboratories (NYSE:ABT) Analyst Rating Update
Research firm Zacks has rated Abbott Laboratories (NYSE:ABT) and has ranked it at 2, indicating that for the short term the shares are a buy.
Stocks Witness Heavy Selling On Strength: Abbott Laboratories (NYSE:ABT ...
Many investors are putting up stocks for sale that currently have some strength but are expected to reverse in price. So what they are doing is simple “selling on strength with a view to show weakness in future”.
Q2 Earnings of $0.5 Expected for Abbott Laboratories (NYSE:ABT)
Sell-side Wall Street analysts are anticipating Abbott Laboratories (NYSE:ABT) will post a current quarter earnings per share of $0.5.
Healthcare Value Perspectives on Abbott Laboratories (NYSE:ABT)
We look at Abbott Laboratories (NYSE:ABT) [Trend Analysis] a company in the Medical Appliances & Equipment industry getting a lot of attention at the moment, to assess if it provides value for investors considering buying or selling it.
Abbott Laboratories Receives AA- Credit Rating (ABT)  sleekmoney
Pre-Market News Alert on: NRG Energy (NYSE:NRG), Abbott Laboratories ...
Mylan N.V. (MYL) issued the following statement regarding Abbott Laboratories' (ABT) declared intention to support Mylan's offer to acquire Perrigo Company plc (NYSE: PRGO; TASE) and vote in favor of this acquisition at Mylan's forthcoming shareholder ...
Abbott Laboratories Price Target Update
Abbott Laboratories (NYSE:ABT): 10 Analyst have given the stock of Abbott Laboratories (NYSE:ABT) a near short term price target of $52.1.
Abbott Laboratories Upgraded to "Buy" at Zacks (ABT)  Dakota Financial News
Abbott Laboratories Short Interest Update  Insider Trading Report